Amphastar Reports Form 4 Filing on July 13

Amphastar Pharmaceuticals has filed a Form 4 with the SEC dated July 13, detailing insider trading activity. This filing provides transparency about changes in the ownership of the company’s stock by its executives, which can influence investor perception. Such filings are crucial for maintaining regulatory compliance and informing shareholders about potential shifts in company control. Monitoring these filings can help investors make informed decisions regarding their investment in Amphastar (AMPH).